Elite Pharmaceuticals Inc (ELTP)
0.4999
-0.02
(-2.93%)
USD |
OTCM |
Nov 07, 16:00
Elite Pharmaceuticals Revenue (TTM): 66.45M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 66.45M |
| March 31, 2024 | 56.63M |
| December 31, 2023 | 47.32M |
| September 30, 2023 | 41.03M |
| June 30, 2023 | 35.46M |
| March 31, 2023 | 34.15M |
| December 31, 2022 | 33.18M |
| September 30, 2022 | 32.91M |
| June 30, 2022 | 32.88M |
| March 31, 2022 | 32.26M |
| December 31, 2021 | 28.99M |
| September 30, 2021 | 26.06M |
| June 30, 2021 | 24.90M |
| March 31, 2021 | 25.38M |
| December 31, 2020 | 25.93M |
| September 30, 2020 | 24.94M |
| June 30, 2020 | 22.17M |
| March 31, 2020 | 17.99M |
| December 31, 2019 | 14.39M |
| September 30, 2019 | 12.03M |
| June 30, 2019 | 8.760M |
| March 31, 2019 | 7.568M |
| December 31, 2018 | 7.822M |
| September 30, 2018 | 7.663M |
| June 30, 2018 | 7.924M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.459M |
| December 31, 2017 | 7.212M |
| September 30, 2017 | 7.007M |
| June 30, 2017 | 8.069M |
| March 31, 2017 | 9.638M |
| December 31, 2016 | 13.48M |
| September 30, 2016 | 13.35M |
| June 30, 2016 | 13.61M |
| March 31, 2016 | 12.50M |
| December 31, 2015 | 8.538M |
| September 30, 2015 | 7.707M |
| June 30, 2015 | 6.017M |
| March 31, 2015 | 5.015M |
| December 31, 2014 | 4.808M |
| September 30, 2014 | 5.139M |
| June 30, 2014 | 5.041M |
| March 31, 2014 | 4.601M |
| December 31, 2013 | 5.097M |
| September 30, 2013 | 4.071M |
| June 30, 2013 | 3.547M |
| March 31, 2013 | 3.404M |
| December 31, 2012 | 2.531M |
| September 30, 2012 | 2.373M |
| June 30, 2012 | 2.013M |
| March 31, 2012 | 2.424M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.39M
Minimum
Dec 2019
66.45M
Maximum
Jun 2024
32.79M
Average
32.26M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Biomarin Pharmaceutical Inc | 2.753B |
| BioCardia Inc | 0.428M |
| Zevra Therapeutics Inc | 23.99M |
| Verrica Pharmaceuticals Inc | 9.21M |
| Terns Pharmaceuticals Inc | -- |